Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frech

Showing results (91-100 of 164) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Rheumatology|May 19, 2011
Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distentionTracy M Frech, Dinesh Khanna, Paul Maranian, et al.
Clinical and Experimental Rheumatology|July 14, 2026
Phosphodiesterase-5 inhibitors, but not calcium channel blockers, improve peripheral vascular function in systemic sclerosisDaniel R Machin, Jordan Tucker, Samuel Bloom, et al.
Best Practice & Research. Clinical Rheumatology|January 7, 2023
Novel therapies and innovation for systemic sclerosis skin ulcerationTracy M Frech, Madeleine Frech, Inga Saknite, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Oesophageal disease in systemic sclerosis: does heritability play a role?Tracy M Frech, Latifa Fakoya, Andrew J Gawron, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1994
Crystallization and preliminary X-ray structure analysis of thermally unstable p21(H-ras) guanosine complexesK Scheffzek, W Kabsch, I Schlichting, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosisDaniel R Machin, Heather L Clifton, Russell S Richardson, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 7, 2018
Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?Tracy M Frech, Rachel Hess, Joshua Biber, et al.
Cell|August 10, 1990
Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch moleculesU Krengel, I Schlichting, A Scherer, et al.
Biochemistry|March 22, 1994
Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical studyM Frech, T A Darden, L G Pedersen, et al.
Seminars in Thrombosis and Hemostasis|September 8, 2001
Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagenC S Barnes, B Krafft, M Frech, et al.
Pageof 17

Showing results (91-100 of 164) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Rheumatology|May 19, 2011
Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distentionTracy M Frech, Dinesh Khanna, Paul Maranian, et al.
Clinical and Experimental Rheumatology|July 14, 2026
Phosphodiesterase-5 inhibitors, but not calcium channel blockers, improve peripheral vascular function in systemic sclerosisDaniel R Machin, Jordan Tucker, Samuel Bloom, et al.
Best Practice & Research. Clinical Rheumatology|January 7, 2023
Novel therapies and innovation for systemic sclerosis skin ulcerationTracy M Frech, Madeleine Frech, Inga Saknite, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Oesophageal disease in systemic sclerosis: does heritability play a role?Tracy M Frech, Latifa Fakoya, Andrew J Gawron, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1994
Crystallization and preliminary X-ray structure analysis of thermally unstable p21(H-ras) guanosine complexesK Scheffzek, W Kabsch, I Schlichting, et al.
Clinical and Experimental Rheumatology|October 6, 2017
Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosisDaniel R Machin, Heather L Clifton, Russell S Richardson, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 7, 2018
Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care?Tracy M Frech, Rachel Hess, Joshua Biber, et al.
Cell|August 10, 1990
Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch moleculesU Krengel, I Schlichting, A Scherer, et al.
Biochemistry|March 22, 1994
Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and theoretical studyM Frech, T A Darden, L G Pedersen, et al.
Seminars in Thrombosis and Hemostasis|September 8, 2001
Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagenC S Barnes, B Krafft, M Frech, et al.
Pageof 17